Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Ali Azmy"'
2
Efficient removal of chromium(VI) ions by hexagonal nanosheets of CoAl-MoS4layered double hydroxide
Autor: Subrata Chandra Roy, Mohammad Arifur Rahman, Ahmet Celik, Sydni Wilson, Ali Azmy, Jay Bieber, Ioannis Spanopoulos, Rafiq Islam, Xianchun Zhu, Fengxiang X. Han, Saiful M. Islam
Publikováno v: Journal of Coordination Chemistry. 75:1581-1595
Water pollution by hexavalent chromium, Cr(VI), poses serious concerns due to its detrimental public health effects. In this work, we report the synthesis, characterization, and sorption properties for Cr(VI) by MoS42- intercalated layered double hyd
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ffb3bb8bc696150367716bf27b2b6e4
https://doi.org/10.1080/00958972.2022.2101103
Zobrazit plný text záznamu
6
Accelerated Hypofractionated Radiotherapy and Concurrent Etoposide/Cisplatin in Patients with Limited-Disease SCLC (LD-SCLC)
Autor: Wessam Elghamry, Zeinab Elsayed, Iman Fouad, Sherif Abdel-Wahab, Ali Azmy
Publikováno v: Journal of Cancer Therapy. 11:683-694
Background: The optimal TRT dose/fraction for LD-SCLC remains debatable, and due to increasing number of population in Egypt and number of patients as well, so reducing the duration of radiation therapy is favored. This study was conducted using etop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b18c6f4fca1b7bc080460197d64c8a93
https://doi.org/10.4236/jct.2020.1111058
Zobrazit plný text záznamu
7
Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)
Autor: A. Mahmoud, Hany Abdel-Aziz, Sherif Abdel-Wahab, H. Salim, Ali Azmy
Publikováno v: Journal of Cancer Research and Clinical Oncology. 138:1487-1492
This study was conducted to test the efficacy and toxicity of cetuximab and irinotecan as a biweekly regimen in treatment of elderly patients with metastatic colorectal cancer (mCRC).Forty-nine elderly patients (≥65 years) with mCRC who progressed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abee7e974d370aeba6ad1db50bacce91
https://doi.org/10.1007/s00432-012-1229-8
Zobrazit plný text záznamu
8
Integration of irinotecan and cisplatin with early concurrent conventional radiotherapy for limited-disease SCLC (LD-SCLC)
Autor: Hany Abdel-Aziz, Maha Margerges, Ibrahim A Dwedar, Ali Azmy, Sherif Abdel-Wahab, Atef Youssef Riad, Hatem Abdulla, Vinay Sharma, Ahmed Abdel-sattar Abdel-fatah
Publikováno v: International Journal of Clinical Oncology. 14:230-236
This study was conducted using irinotecan and cisplatin (IP) concurrently with thoracic radiation therapy to evaluate the response and toxicity of this protocol in the treatment of patients with limited-disease small cell lung cancer (LD-SCLC).Twenty
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d1529af16a97ac468de7273f97205a
https://doi.org/10.1007/s10147-008-0842-7
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje